Frequency Therapeutics, Inc. (FREQ)
- Business Wire
Frequency Therapeutics to Participate in September Investor and Medical Conferences
LEXINGTON, Mass., August 30, 2022--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced that members of its management team will participate in investor and medical conferences later this month.
- Business Wire
Frequency Therapeutics Provides Business Updates and Second Quarter 2022 Financial Results
LEXINGTON, Mass., August 09, 2022--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate potential to restore function, today announced business updates and financial results for the second quarter ended June 30, 2022.
- Simply Wall St.
Frequency Therapeutics (NASDAQ:FREQ) one-year losses have grown faster than shareholder returns have fallen, but the stock jumps 41% this past week
Frequency Therapeutics, Inc. ( NASDAQ:FREQ ) shareholders will doubtless be very grateful to see the share price up 41...
